It is widely recognized that the two major forms of GAD present in adult ve
rtebrate brains are each composed of two major sequence domains that differ
in size and degree of similarity. The amino-terminal domain is smaller and
shows little sequence identity between the two forms. This domain is thoug
ht to mediate the subcellular targeting of the two GADs. Substantial parts
of the amino-terminal domain appear to be exposed and flexible, as shown by
proteolysis experiments and the locations of posttranslational modificatio
ns. The carboxyl-terminal sequence domain contains the catalytic site and s
hows substantial sequence similarity between the forms. The interaction of
GAD with its cofactor, pyridoxal-5' phosphate (pyridoxal-P), plays a key ro
le in the regulation of CAD activity. Although GAD(65) and GAD(67) interact
differently with pyridoxal-P, their cofactor-binding sites contain the sam
e set of nine putative cofactor-binding residues and have the same basic st
ructural fold. Thus the cofactor-binding differences cannot be attributed t
o fundamental structural differences between the GADs but must result from
subtle modifications of the basic cofactor-binding fold. The presence of an
other conserved motif suggests that the carboxylterminal domain is composed
of two functional domains: the cofactor-binding domain and a small domain
that closes when the substrate binds. Finally, GAD is a dimeric enzyme and
conserved features of GADs superfamily of pyridoxal-P proteins indicate the
dimer-forming interactions are mediated mainly by the carboxyl-terminal do
main. Published by Elsevier Science Ltd.